Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.55985821746421.
The log-likelihood improved by 4.595.
Iteration 2 of at most 500:
Optimizing with step length 0.541449353236669.
The log-likelihood improved by 2.294.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.9832.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.1039.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       2       18     1280     1079      822      350      359      344 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     266      180      128       88       38       25       13        5 
degree17 
       3 
1 
disease_progression 
H-positive risk:  881 900 127 863 437 118 885 449 114 51 124 51 
H-negative risk:  900 881 885 863 449 437 118 127 124 114 51 51 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
53 new agents 
2 
disease_progression 
H-positive risk:  890 902 129 858 430 118 885 447 114 51 125 51 
H-negative risk:  902 890 885 858 447 430 118 129 125 114 51 51 
New BC onsets:  2
BC status:  4998 2 
BC subtype:  4998 2 

clinical_engagement 
diagnosis 
demography 
51 new agents 
3 
disease_progression 
H-positive risk:  892 902 130 860 427 118 891 442 111 52 125 50 
H-negative risk:  902 892 891 860 442 427 118 130 125 111 50 52 
New BC onsets:  4
BC status:  4996 4 
BC subtype:  4996 4 

clinical_engagement 
diagnosis 
demography 
46 new agents 
4 
disease_progression 
H-positive risk:  899 903 131 859 423 119 894 434 112 53 124 49 
H-negative risk:  903 899 894 859 434 423 119 131 124 112 49 53 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 5 

clinical_engagement 
diagnosis 
demography 
63 new agents 
5 
disease_progression 
H-positive risk:  897 915 132 850 421 122 902 428 111 53 120 49 
H-negative risk:  915 897 902 850 428 421 122 132 120 111 49 53 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 9 

clinical_engagement 
diagnosis 
demography 
54 new agents 
6 
disease_progression 
H-positive risk:  899 920 133 844 416 120 911 422 111 51 123 50 
H-negative risk:  920 899 911 844 422 416 120 133 123 111 50 51 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 10 

clinical_engagement 
diagnosis 
demography 
56 new agents 
7 
disease_progression 
H-positive risk:  902 924 132 836 420 120 915 414 111 51 123 52 
H-negative risk:  924 902 915 836 414 420 120 132 123 111 52 51 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 14 

clinical_engagement 
diagnosis 
demography 
70 new agents 
8 
disease_progression 
H-positive risk:  907 926 132 836 416 120 915 413 110 51 122 52 
H-negative risk:  926 907 915 836 413 416 120 132 122 110 52 51 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 16 2 

clinical_engagement 
diagnosis 
demography 
53 new agents 
9 
disease_progression 
H-positive risk:  912 923 135 836 415 122 914 408 108 52 123 52 
H-negative risk:  923 912 914 836 408 415 122 135 123 108 52 52 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 20 2 

clinical_engagement 
diagnosis 
demography 
57 new agents 
10 
disease_progression 
H-positive risk:  916 927 135 834 411 123 915 406 108 49 125 51 
H-negative risk:  927 916 915 834 406 411 123 135 125 108 51 49 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 22 2 

clinical_engagement 
diagnosis 
demography 
73 new agents 
11 
disease_progression 
H-positive risk:  919 936 139 844 410 125 901 402 106 48 120 50 
H-negative risk:  936 919 901 844 402 410 125 139 120 106 50 48 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 25 4 

clinical_engagement 
diagnosis 
demography 
56 new agents 
12 
disease_progression 
H-positive risk:  931 941 139 845 403 126 901 392 107 47 119 49 
H-negative risk:  941 931 901 845 392 403 126 139 119 107 49 47 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 29 4 

clinical_engagement 
diagnosis 
demography 
61 new agents 
13 
disease_progression 
H-positive risk:  843 857 130 925 399 106 995 395 126 48 126 50 
H-negative risk:  857 843 995 925 395 399 106 130 126 126 50 48 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 30 5 

clinical_engagement 
diagnosis 
demography 
202 new agents 
14 
disease_progression 
H-positive risk:  878 890 136 881 404 107 942 417 123 53 116 53 
H-negative risk:  890 878 942 881 417 404 107 136 116 123 53 53 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 30 6 

clinical_engagement 
diagnosis 
demography 
68 new agents 
15 
disease_progression 
H-positive risk:  889 890 136 886 398 106 937 417 120 54 114 53 
H-negative risk:  890 889 937 886 417 398 106 136 114 120 53 54 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 30 6 

clinical_engagement 
diagnosis 
demography 
51 new agents 
16 
disease_progression 
H-positive risk:  885 902 134 881 397 107 932 419 119 55 114 55 
H-negative risk:  902 885 932 881 419 397 107 134 114 119 55 55 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 31 6 

clinical_engagement 
diagnosis 
demography 
63 new agents 
17 
disease_progression 
H-positive risk:  897 909 132 881 389 108 928 415 118 54 114 55 
H-negative risk:  909 897 928 881 415 389 108 132 114 118 55 54 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 33 7 

clinical_engagement 
diagnosis 
demography 
63 new agents 
18 
disease_progression 
H-positive risk:  904 915 131 876 385 109 926 416 116 54 112 56 
H-negative risk:  915 904 926 876 416 385 109 131 112 116 56 54 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 35 8 

clinical_engagement 
diagnosis 
demography 
48 new agents 
19 
disease_progression 
H-positive risk:  912 914 131 873 385 109 928 413 117 53 109 56 
H-negative risk:  914 912 928 873 413 385 109 131 109 117 56 53 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 35 8 

clinical_engagement 
diagnosis 
demography 
49 new agents 
20 
disease_progression 
H-positive risk:  912 918 133 876 379 108 929 410 116 53 108 58 
H-negative risk:  918 912 929 876 410 379 108 133 108 116 58 53 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 34 7 

clinical_engagement 
diagnosis 
demography 
69 new agents 
21 
disease_progression 
H-positive risk:  916 922 132 882 383 108 925 398 115 52 108 59 
H-negative risk:  922 916 925 882 398 383 108 132 108 115 59 52 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 36 7 

clinical_engagement 
diagnosis 
demography 
49 new agents 
22 
disease_progression 
H-positive risk:  913 922 132 879 384 109 930 396 114 53 110 58 
H-negative risk:  922 913 930 879 396 384 109 132 110 114 58 53 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 36 6 

clinical_engagement 
diagnosis 
demography 
59 new agents 
23 
disease_progression 
H-positive risk:  914 921 134 877 382 108 931 398 116 53 109 57 
H-negative risk:  921 914 931 877 398 382 108 134 109 116 57 53 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 36 6 

clinical_engagement 
diagnosis 
demography 
51 new agents 
24 
disease_progression 
H-positive risk:  920 918 136 879 376 106 934 402 115 53 106 55 
H-negative risk:  918 920 934 879 402 376 106 136 106 115 55 53 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 36 6 

clinical_engagement 
diagnosis 
demography 
62 new agents 
25 
disease_progression 
H-positive risk:  832 849 128 947 376 99 1025 397 126 53 115 53 
H-negative risk:  849 832 1025 947 397 376 99 128 115 126 53 53 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 37 6 

clinical_engagement 
diagnosis 
demography 
182 new agents 
26 
disease_progression 
H-positive risk:  848 871 132 914 400 100 986 414 128 45 108 54 
H-negative risk:  871 848 986 914 414 400 100 132 108 128 54 45 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 40 8 

clinical_engagement 
diagnosis 
demography 
64 new agents 
27 
disease_progression 
H-positive risk:  850 879 129 907 397 103 985 420 127 43 108 52 
H-negative risk:  879 850 985 907 420 397 103 129 108 127 52 43 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 43 9 

clinical_engagement 
diagnosis 
demography 
65 new agents 
28 
disease_progression 
H-positive risk:  855 886 130 904 393 102 980 418 128 44 108 52 
H-negative risk:  886 855 980 904 418 393 102 130 108 128 52 44 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 43 9 

clinical_engagement 
diagnosis 
demography 
59 new agents 
29 
disease_progression 
H-positive risk:  855 883 132 905 395 102 975 421 132 43 108 49 
H-negative risk:  883 855 975 905 421 395 102 132 108 132 49 43 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 43 10 

clinical_engagement 
diagnosis 
demography 
67 new agents 
30 
disease_progression 
H-positive risk:  862 885 134 909 389 102 963 425 132 43 109 47 
H-negative risk:  885 862 963 909 425 389 102 134 109 132 47 43 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 43 10 

clinical_engagement 
diagnosis 
demography 
60 new agents 
31 
disease_progression 
H-positive risk:  864 890 139 906 384 105 964 421 132 44 104 47 
H-negative risk:  890 864 964 906 421 384 105 139 104 132 47 44 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 44 10 

clinical_engagement 
diagnosis 
demography 
67 new agents 
32 
disease_progression 
H-positive risk:  864 890 138 910 383 105 960 418 133 44 106 49 
H-negative risk:  890 864 960 910 418 383 105 138 106 133 49 44 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 43 10 

clinical_engagement 
diagnosis 
demography 
65 new agents 
33 
disease_progression 
H-positive risk:  862 885 138 911 384 109 963 419 131 44 108 46 
H-negative risk:  885 862 963 911 419 384 109 138 108 131 46 44 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 44 10 

clinical_engagement 
diagnosis 
demography 
56 new agents 
34 
disease_progression 
H-positive risk:  864 889 137 904 386 109 966 416 131 44 108 46 
H-negative risk:  889 864 966 904 416 386 109 137 108 131 46 44 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 44 10 

clinical_engagement 
diagnosis 
demography 
53 new agents 
35 
disease_progression 
H-positive risk:  867 890 138 902 383 109 966 416 132 44 108 45 
H-negative risk:  890 867 966 902 416 383 109 138 108 132 45 44 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 47 11 

clinical_engagement 
diagnosis 
demography 
72 new agents 
36 
disease_progression 
H-positive risk:  871 893 142 907 379 109 964 410 132 44 105 44 
H-negative risk:  893 871 964 907 410 379 109 142 105 132 44 44 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 47 11 

clinical_engagement 
diagnosis 
demography 
68 new agents 
37 
disease_progression 
H-positive risk:  816 821 136 982 375 102 1020 409 140 44 111 44 
H-negative risk:  821 816 1020 982 409 375 102 136 111 140 44 44 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 48 11 

clinical_engagement 
diagnosis 
demography 
126 new agents 
38 
disease_progression 
H-positive risk:  833 829 136 931 405 106 985 437 141 41 106 50 
H-negative risk:  829 833 985 931 437 405 106 136 106 141 50 41 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 49 13 

clinical_engagement 
diagnosis 
demography 
82 new agents 
39 
disease_progression 
H-positive risk:  843 841 135 927 399 105 981 431 138 42 104 54 
H-negative risk:  841 843 981 927 431 399 105 135 104 138 54 42 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 45 15 

clinical_engagement 
diagnosis 
demography 
73 new agents 
40 
disease_progression 
H-positive risk:  847 842 138 928 400 105 979 423 136 43 106 53 
H-negative risk:  842 847 979 928 423 400 105 138 106 136 53 43 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 46 15 

clinical_engagement 
diagnosis 
demography 
79 new agents 
41 
disease_progression 
H-positive risk:  853 842 137 938 392 106 974 420 136 44 104 54 
H-negative risk:  842 853 974 938 420 392 106 137 104 136 54 44 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 48 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
42 
disease_progression 
H-positive risk:  855 847 135 933 391 108 978 413 134 44 108 54 
H-negative risk:  847 855 978 933 413 391 108 135 108 134 54 44 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 48 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
43 
disease_progression 
H-positive risk:  854 854 137 938 387 110 981 402 132 44 104 57 
H-negative risk:  854 854 981 938 402 387 110 137 104 132 57 44 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 49 16 

clinical_engagement 
diagnosis 
demography 
64 new agents 
44 
disease_progression 
H-positive risk:  860 863 137 941 384 110 972 403 131 42 101 56 
H-negative risk:  863 860 972 941 403 384 110 137 101 131 56 42 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 50 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
45 
disease_progression 
H-positive risk:  857 867 138 936 382 110 975 403 133 44 101 54 
H-negative risk:  867 857 975 936 403 382 110 138 101 133 54 44 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 51 14 

clinical_engagement 
diagnosis 
demography 
76 new agents 
46 
disease_progression 
H-positive risk:  861 873 137 939 380 107 971 396 137 43 100 56 
H-negative risk:  873 861 971 939 396 380 107 137 100 137 56 43 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 49 14 

clinical_engagement 
diagnosis 
demography 
50 new agents 
47 
disease_progression 
H-positive risk:  866 874 135 937 375 107 968 401 138 43 100 56 
H-negative risk:  874 866 968 937 401 375 107 135 100 138 56 43 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 47 15 

clinical_engagement 
diagnosis 
demography 
65 new agents 
48 
disease_progression 
H-positive risk:  864 883 136 935 368 108 966 397 139 45 103 56 
H-negative risk:  883 864 966 935 397 368 108 136 103 139 56 45 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 45 16 

clinical_engagement 
diagnosis 
demography 
66 new agents 
49 
disease_progression 
H-positive risk:  796 816 125 1013 365 100 1032 391 148 43 114 57 
H-negative risk:  816 796 1032 1013 391 365 100 125 114 148 57 43 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 47 18 

clinical_engagement 
diagnosis 
demography 
162 new agents 
50 
disease_progression 
H-positive risk:  808 832 128 996 364 102 989 412 139 49 114 67 
H-negative risk:  832 808 989 996 412 364 102 128 114 139 67 49 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 47 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
51 
disease_progression 
H-positive risk:  805 834 128 994 358 101 995 413 140 52 114 66 
H-negative risk:  834 805 995 994 413 358 101 128 114 140 66 52 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 49 18 

clinical_engagement 
diagnosis 
demography 
59 new agents 
52 
disease_progression 
H-positive risk:  802 834 128 1004 352 99 1000 409 139 53 115 65 
H-negative risk:  834 802 1000 1004 409 352 99 128 115 139 65 53 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 49 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
53 
disease_progression 
H-positive risk:  808 831 130 1005 352 98 1002 400 140 51 115 68 
H-negative risk:  831 808 1002 1005 400 352 98 130 115 140 68 51 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 53 20 

clinical_engagement 
diagnosis 
demography 
48 new agents 
54 
disease_progression 
H-positive risk:  806 835 128 1011 356 98 1002 397 137 53 115 62 
H-negative risk:  835 806 1002 1011 397 356 98 128 115 137 62 53 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 54 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
55 
disease_progression 
H-positive risk:  807 838 132 1008 352 97 1001 396 139 53 113 64 
H-negative risk:  838 807 1001 1008 396 352 97 132 113 139 64 53 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 52 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
56 
disease_progression 
H-positive risk:  812 841 129 1013 347 99 996 393 140 53 114 63 
H-negative risk:  841 812 996 1013 393 347 99 129 114 140 63 53 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 54 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
57 
disease_progression 
H-positive risk:  814 843 132 1016 344 100 994 389 139 55 112 62 
H-negative risk:  843 814 994 1016 389 344 100 132 112 139 62 55 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 52 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
58 
disease_progression 
H-positive risk:  815 847 134 1019 342 99 992 388 136 54 114 60 
H-negative risk:  847 815 992 1019 388 342 99 134 114 136 60 54 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 54 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
59 
disease_progression 
H-positive risk:  818 855 135 1020 333 98 990 389 137 50 115 60 
H-negative risk:  855 818 990 1020 389 333 98 135 115 137 60 50 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 55 23 

clinical_engagement 
diagnosis 
demography 
60 new agents 
60 
disease_progression 
H-positive risk:  819 854 136 1023 331 100 985 386 139 52 115 60 
H-negative risk:  854 819 985 1023 386 331 100 136 115 139 60 52 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 57 23 

clinical_engagement 
diagnosis 
demography 
56 new agents 
61 
disease_progression 
H-positive risk:  771 809 128 1066 329 99 1033 391 142 51 122 59 
H-negative risk:  809 771 1033 1066 391 329 99 128 122 142 59 51 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 59 22 

clinical_engagement 
diagnosis 
demography 
138 new agents 
62 
disease_progression 
H-positive risk:  780 822 126 1040 334 100 1021 407 136 53 122 59 
H-negative risk:  822 780 1021 1040 407 334 100 126 122 136 59 53 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 59 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
63 
disease_progression 
H-positive risk:  777 820 126 1036 340 104 1025 403 135 53 120 61 
H-negative risk:  820 777 1025 1036 403 340 104 126 120 135 61 53 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 56 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
64 
disease_progression 
H-positive risk:  775 826 128 1035 342 106 1025 394 135 53 121 60 
H-negative risk:  826 775 1025 1035 394 342 106 128 121 135 60 53 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 56 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
65 
disease_progression 
H-positive risk:  771 825 128 1039 343 106 1028 393 133 54 121 59 
H-negative risk:  825 771 1028 1039 393 343 106 128 121 133 59 54 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 57 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
66 
disease_progression 
H-positive risk:  767 819 124 1045 341 107 1034 394 135 53 120 61 
H-negative risk:  819 767 1034 1045 394 341 107 124 120 135 61 53 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 61 19 

clinical_engagement 
diagnosis 
demography 
87 new agents 
67 
disease_progression 
H-positive risk:  781 828 124 1029 347 106 1033 384 137 50 122 59 
H-negative risk:  828 781 1033 1029 384 347 106 124 122 137 59 50 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 61 21 

clinical_engagement 
diagnosis 
demography 
53 new agents 
68 
disease_progression 
H-positive risk:  783 824 125 1027 346 106 1033 384 139 52 124 57 
H-negative risk:  824 783 1033 1027 384 346 106 125 124 139 57 52 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 60 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
69 
disease_progression 
H-positive risk:  781 833 125 1018 343 108 1040 381 138 53 124 56 
H-negative risk:  833 781 1040 1018 381 343 108 125 124 138 56 53 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 60 22 

clinical_engagement 
diagnosis 
demography 
59 new agents 
70 
disease_progression 
H-positive risk:  789 828 128 1015 336 109 1040 386 136 52 125 56 
H-negative risk:  828 789 1040 1015 386 336 109 128 125 136 56 52 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 61 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
71 
disease_progression 
H-positive risk:  790 827 129 1016 332 112 1039 386 134 54 123 58 
H-negative risk:  827 790 1039 1016 386 332 112 129 123 134 58 54 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 62 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
72 
disease_progression 
H-positive risk:  794 832 126 1009 340 114 1036 381 131 54 126 57 
H-negative risk:  832 794 1036 1009 381 340 114 126 126 131 57 54 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 64 24 

clinical_engagement 
diagnosis 
demography 
60 new agents 
73 
disease_progression 
H-positive risk:  751 780 122 1058 343 104 1077 383 138 55 131 58 
H-negative risk:  780 751 1077 1058 383 343 104 122 131 138 58 55 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
112 new agents 
74 
disease_progression 
H-positive risk:  748 785 124 1055 347 105 1061 396 137 52 130 60 
H-negative risk:  785 748 1061 1055 396 347 105 124 130 137 60 52 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 63 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
75 
disease_progression 
H-positive risk:  750 789 129 1058 346 108 1062 390 134 52 128 54 
H-negative risk:  789 750 1062 1058 390 346 108 129 128 134 54 52 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 65 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
76 
disease_progression 
H-positive risk:  747 791 126 1047 355 107 1065 388 135 53 132 54 
H-negative risk:  791 747 1065 1047 388 355 107 126 132 135 54 53 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
77 
disease_progression 
H-positive risk:  753 789 124 1047 359 108 1065 382 134 53 130 56 
H-negative risk:  789 753 1065 1047 382 359 108 124 130 134 56 53 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
78 
disease_progression 
H-positive risk:  756 790 127 1050 353 109 1058 387 132 52 131 55 
H-negative risk:  790 756 1058 1050 387 353 109 127 131 132 55 52 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 66 24 

clinical_engagement 
diagnosis 
demography 
48 new agents 
79 
disease_progression 
H-positive risk:  757 788 121 1052 349 111 1062 387 131 51 136 55 
H-negative risk:  788 757 1062 1052 387 349 111 121 136 131 55 51 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
80 
disease_progression 
H-positive risk:  766 786 124 1046 348 113 1063 385 127 52 137 53 
H-negative risk:  786 766 1063 1046 385 348 113 124 137 127 53 52 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
81 
disease_progression 
H-positive risk:  769 786 124 1045 345 111 1064 379 131 55 137 54 
H-negative risk:  786 769 1064 1045 379 345 111 124 137 131 54 55 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
82 
disease_progression 
H-positive risk:  764 798 120 1046 341 110 1064 376 135 54 138 54 
H-negative risk:  798 764 1064 1046 376 341 110 120 138 135 54 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
83 
disease_progression 
H-positive risk:  759 792 119 1049 343 111 1065 372 140 55 140 55 
H-negative risk:  792 759 1065 1049 372 343 111 119 140 140 55 55 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 69 23 

clinical_engagement 
diagnosis 
demography 
58 new agents 
84 
disease_progression 
H-positive risk:  768 789 119 1050 343 108 1061 367 144 56 141 54 
H-negative risk:  789 768 1061 1050 367 343 108 119 141 144 54 56 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 68 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
85 
disease_progression 
H-positive risk:  737 757 111 1089 344 106 1093 357 149 56 149 52 
H-negative risk:  757 737 1093 1089 357 344 106 111 149 149 52 56 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 68 22 

clinical_engagement 
diagnosis 
demography 
112 new agents 
86 
disease_progression 
H-positive risk:  737 752 113 1083 346 103 1085 375 150 56 146 54 
H-negative risk:  752 737 1085 1083 375 346 103 113 146 150 54 56 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
87 
disease_progression 
H-positive risk:  736 755 113 1079 349 106 1088 372 147 54 145 56 
H-negative risk:  755 736 1088 1079 372 349 106 113 145 147 56 54 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 73 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
88 
disease_progression 
H-positive risk:  732 756 113 1076 346 107 1087 378 146 57 146 56 
H-negative risk:  756 732 1087 1076 378 346 107 113 146 146 56 57 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
89 
disease_progression 
H-positive risk:  736 753 116 1074 347 107 1080 382 145 55 148 57 
H-negative risk:  753 736 1080 1074 382 347 107 116 148 145 57 55 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
90 
disease_progression 
H-positive risk:  741 749 120 1071 357 109 1072 383 145 53 147 53 
H-negative risk:  749 741 1072 1071 383 357 109 120 147 145 53 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
91 
disease_progression 
H-positive risk:  746 754 118 1067 358 111 1077 376 143 53 145 52 
H-negative risk:  754 746 1077 1067 376 358 111 118 145 143 52 53 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
92 
disease_progression 
H-positive risk:  748 759 117 1068 354 110 1066 384 142 55 148 49 
H-negative risk:  759 748 1066 1068 384 354 110 117 148 142 49 55 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 78 16 

clinical_engagement 
diagnosis 
demography 
61 new agents 
93 
disease_progression 
H-positive risk:  753 763 115 1071 348 110 1061 385 141 54 149 50 
H-negative risk:  763 753 1061 1071 385 348 110 115 149 141 50 54 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 75 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
94 
disease_progression 
H-positive risk:  763 762 118 1083 338 112 1060 376 139 55 148 46 
H-negative risk:  762 763 1060 1083 376 338 112 118 148 139 46 55 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 73 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
95 
disease_progression 
H-positive risk:  769 764 117 1076 343 111 1059 375 137 56 148 45 
H-negative risk:  764 769 1059 1076 375 343 111 117 148 137 45 56 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 74 18 

clinical_engagement 
diagnosis 
demography 
62 new agents 
96 
disease_progression 
H-positive risk:  770 764 121 1075 345 111 1056 372 133 58 149 46 
H-negative risk:  764 770 1056 1075 372 345 111 121 149 133 46 58 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 70 17 

clinical_engagement 
diagnosis 
demography 
79 new agents 
97 
disease_progression 
H-positive risk:  723 707 109 1126 342 103 1104 383 140 59 157 47 
H-negative risk:  707 723 1104 1126 383 342 103 109 157 140 47 59 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 75 17 

clinical_engagement 
diagnosis 
demography 
112 new agents 
98 
disease_progression 
H-positive risk:  725 697 112 1110 359 104 1083 406 142 63 152 47 
H-negative risk:  697 725 1083 1110 406 359 104 112 152 142 47 63 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
82 new agents 
99 
disease_progression 
H-positive risk:  726 696 111 1099 367 101 1093 406 140 62 152 47 
H-negative risk:  696 726 1093 1099 406 367 101 111 152 140 47 62 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 66 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
100 
disease_progression 
H-positive risk:  723 705 113 1092 367 102 1085 413 137 63 151 49 
H-negative risk:  705 723 1085 1092 413 367 102 113 151 137 49 63 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
101 
disease_progression 
H-positive risk:  723 705 111 1087 366 103 1102 411 134 61 150 47 
H-negative risk:  705 723 1102 1087 411 366 103 111 150 134 47 61 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 68 19 

clinical_engagement 
diagnosis 
demography 
85 new agents 
102 
disease_progression 
H-positive risk:  719 707 117 1082 364 102 1112 405 139 58 150 45 
H-negative risk:  707 719 1112 1082 405 364 102 117 150 139 45 58 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 66 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
103 
disease_progression 
H-positive risk:  718 702 117 1100 358 102 1112 404 134 59 150 44 
H-negative risk:  702 718 1112 1100 404 358 102 117 150 134 44 59 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 66 18 

clinical_engagement 
diagnosis 
demography 
86 new agents 
104 
disease_progression 
H-positive risk:  725 703 116 1106 355 100 1104 402 135 59 154 41 
H-negative risk:  703 725 1104 1106 402 355 100 116 154 135 41 59 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 69 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
105 
disease_progression 
H-positive risk:  723 698 117 1117 354 98 1100 403 137 58 154 41 
H-negative risk:  698 723 1100 1117 403 354 98 117 154 137 41 58 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 69 15 

clinical_engagement 
diagnosis 
demography 
63 new agents 
106 
disease_progression 
H-positive risk:  732 690 117 1119 352 99 1096 404 138 59 156 38 
H-negative risk:  690 732 1096 1119 404 352 99 117 156 138 38 59 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 67 15 

clinical_engagement 
diagnosis 
demography 
78 new agents 
107 
disease_progression 
H-positive risk:  737 685 113 1125 345 101 1091 410 139 60 157 37 
H-negative risk:  685 737 1091 1125 410 345 101 113 157 139 37 60 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 68 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
108 
disease_progression 
H-positive risk:  741 696 115 1117 347 104 1089 403 137 57 157 37 
H-negative risk:  696 741 1089 1117 403 347 104 115 157 137 37 57 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 65 15 

clinical_engagement 
diagnosis 
demography 
67 new agents 
109 
disease_progression 
H-positive risk:  703 658 110 1157 350 99 1123 401 143 58 160 38 
H-negative risk:  658 703 1123 1157 401 350 99 110 160 143 38 58 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 66 15 

clinical_engagement 
diagnosis 
demography 
89 new agents 
110 
disease_progression 
H-positive risk:  704 657 109 1151 367 97 1102 412 140 58 164 39 
H-negative risk:  657 704 1102 1151 412 367 97 109 164 140 39 58 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 65 14 

clinical_engagement 
diagnosis 
demography 
78 new agents 
111 
disease_progression 
H-positive risk:  709 658 108 1152 373 97 1098 410 136 58 161 40 
H-negative risk:  658 709 1098 1152 410 373 97 108 161 136 40 58 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 68 14 

clinical_engagement 
diagnosis 
demography 
62 new agents 
112 
disease_progression 
H-positive risk:  706 658 109 1161 375 100 1093 409 134 58 159 38 
H-negative risk:  658 706 1093 1161 409 375 100 109 159 134 38 58 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 70 13 

clinical_engagement 
diagnosis 
demography 
87 new agents 
113 
disease_progression 
H-positive risk:  712 660 108 1153 369 105 1095 405 138 55 158 42 
H-negative risk:  660 712 1095 1153 405 369 105 108 158 138 42 55 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 71 12 

clinical_engagement 
diagnosis 
demography 
76 new agents 
114 
disease_progression 
H-positive risk:  715 664 108 1164 358 108 1079 412 139 52 159 42 
H-negative risk:  664 715 1079 1164 412 358 108 108 159 139 42 52 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 72 12 

clinical_engagement 
diagnosis 
demography 
71 new agents 
115 
disease_progression 
H-positive risk:  710 658 111 1172 354 110 1080 412 138 53 161 41 
H-negative risk:  658 710 1080 1172 412 354 110 111 161 138 41 53 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 70 12 

clinical_engagement 
diagnosis 
demography 
70 new agents 
116 
disease_progression 
H-positive risk:  711 659 110 1167 359 111 1086 407 135 53 161 41 
H-negative risk:  659 711 1086 1167 407 359 111 110 161 135 41 53 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 72 11 

clinical_engagement 
diagnosis 
demography 
81 new agents 
117 
disease_progression 
H-positive risk:  720 661 111 1165 355 107 1083 407 136 54 157 44 
H-negative risk:  661 720 1083 1165 407 355 107 111 157 136 44 54 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 73 12 

clinical_engagement 
diagnosis 
demography 
80 new agents 
118 
disease_progression 
H-positive risk:  721 655 114 1164 359 105 1095 401 137 48 154 47 
H-negative risk:  655 721 1095 1164 401 359 105 114 154 137 47 48 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 75 12 

clinical_engagement 
diagnosis 
demography 
75 new agents 
119 
disease_progression 
H-positive risk:  724 659 110 1155 361 104 1097 406 135 48 156 45 
H-negative risk:  659 724 1097 1155 406 361 104 110 156 135 45 48 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 76 12 

clinical_engagement 
diagnosis 
demography 
67 new agents 
120 
disease_progression 
H-positive risk:  721 660 107 1149 364 100 1106 407 135 49 156 46 
H-negative risk:  660 721 1106 1149 407 364 100 107 156 135 46 49 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 75 11 

clinical_engagement 
diagnosis 
demography 
79 new agents 
121 
disease_progression 
H-positive risk:  688 629 100 1182 366 91 1143 399 145 50 164 43 
H-negative risk:  629 688 1143 1182 399 366 91 100 164 145 43 50 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 77 12 

clinical_engagement 
diagnosis 
demography 
92 new agents 
122 
disease_progression 
H-positive risk:  691 633 95 1163 386 92 1130 408 144 47 168 43 
H-negative risk:  633 691 1130 1163 408 386 92 95 168 144 43 47 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 77 12 

clinical_engagement 
diagnosis 
demography 
83 new agents 
123 
disease_progression 
H-positive risk:  680 638 96 1159 394 89 1138 407 145 46 164 44 
H-negative risk:  638 680 1138 1159 407 394 89 96 164 145 44 46 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 77 10 

clinical_engagement 
diagnosis 
demography 
72 new agents 
124 
disease_progression 
H-positive risk:  683 628 94 1164 389 86 1150 405 146 46 168 41 
H-negative risk:  628 683 1150 1164 405 389 86 94 168 146 41 46 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 79 11 

clinical_engagement 
diagnosis 
demography 
84 new agents 
125 
disease_progression 
H-positive risk:  690 637 93 1153 380 83 1155 402 148 47 171 41 
H-negative risk:  637 690 1155 1153 402 380 83 93 171 148 41 47 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 79 10 

clinical_engagement 
diagnosis 
demography 
81 new agents 
126 
disease_progression 
H-positive risk:  689 634 95 1155 384 82 1155 400 147 48 168 43 
H-negative risk:  634 689 1155 1155 400 384 82 95 168 147 43 48 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 79 11 

clinical_engagement 
diagnosis 
demography 
71 new agents 
127 
disease_progression 
H-positive risk:  688 636 96 1154 383 81 1153 403 147 48 168 43 
H-negative risk:  636 688 1153 1154 403 383 81 96 168 147 43 48 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 79 10 

clinical_engagement 
diagnosis 
demography 
72 new agents 
128 
disease_progression 
H-positive risk:  685 650 99 1152 382 81 1150 398 146 46 167 44 
H-negative risk:  650 685 1150 1152 398 382 81 99 167 146 44 46 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 78 10 

clinical_engagement 
diagnosis 
demography 
70 new agents 
129 
disease_progression 
H-positive risk:  687 654 96 1154 392 84 1135 393 147 43 169 46 
H-negative risk:  654 687 1135 1154 393 392 84 96 169 147 46 43 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 81 11 

clinical_engagement 
diagnosis 
demography 
78 new agents 
130 
disease_progression 
H-positive risk:  679 655 97 1154 393 87 1137 391 148 45 167 47 
H-negative risk:  655 679 1137 1154 391 393 87 97 167 148 47 45 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 81 11 

clinical_engagement 
diagnosis 
demography 
77 new agents 
131 
disease_progression 
H-positive risk:  665 661 100 1152 397 88 1139 390 145 50 163 50 
H-negative risk:  661 665 1139 1152 390 397 88 100 163 145 50 50 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 82 10 

clinical_engagement 
diagnosis 
demography 
83 new agents 
132 
disease_progression 
H-positive risk:  663 657 99 1152 396 88 1149 386 151 48 162 49 
H-negative risk:  657 663 1149 1152 386 396 88 99 162 151 49 48 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 85 11 

clinical_engagement 
diagnosis 
demography 
77 new agents 
133 
disease_progression 
H-positive risk:  660 658 99 1159 397 88 1148 379 154 45 163 50 
H-negative risk:  658 660 1148 1159 379 397 88 99 163 154 50 45 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 84 11 

clinical_engagement 
diagnosis 
demography 
95 new agents 
134 
disease_progression 
H-positive risk:  660 654 101 1140 420 84 1141 389 150 46 164 51 
H-negative risk:  654 660 1141 1140 389 420 84 101 164 150 51 46 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 86 11 

clinical_engagement 
diagnosis 
demography 
74 new agents 
135 
disease_progression 
H-positive risk:  668 649 100 1133 426 85 1135 393 149 46 161 55 
H-negative risk:  649 668 1135 1133 393 426 85 100 161 149 55 46 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 84 11 

clinical_engagement 
diagnosis 
demography 
79 new agents 
136 
disease_progression 
H-positive risk:  667 643 103 1132 432 84 1143 387 152 42 161 54 
H-negative risk:  643 667 1143 1132 387 432 84 103 161 152 54 42 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 83 12 

clinical_engagement 
diagnosis 
demography 
73 new agents 
137 
disease_progression 
H-positive risk:  668 648 105 1128 429 85 1140 385 155 41 161 55 
H-negative risk:  648 668 1140 1128 385 429 85 105 161 155 55 41 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 82 12 

clinical_engagement 
diagnosis 
demography 
66 new agents 
138 
disease_progression 
H-positive risk:  661 649 105 1126 428 86 1141 391 155 42 161 55 
H-negative risk:  649 661 1141 1126 391 428 86 105 161 155 55 42 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 82 12 

clinical_engagement 
diagnosis 
demography 
68 new agents 
139 
disease_progression 
H-positive risk:  664 646 103 1124 426 84 1136 395 158 42 166 56 
H-negative risk:  646 664 1136 1124 395 426 84 103 166 158 56 42 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 82 12 

clinical_engagement 
diagnosis 
demography 
62 new agents 
140 
disease_progression 
H-positive risk:  664 646 102 1116 428 84 1139 396 160 39 169 57 
H-negative risk:  646 664 1139 1116 396 428 84 102 169 160 57 39 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 85 12 

clinical_engagement 
diagnosis 
demography 
79 new agents 
141 
disease_progression 
H-positive risk:  665 651 104 1110 433 85 1136 393 163 36 167 57 
H-negative risk:  651 665 1136 1110 393 433 85 104 167 163 57 36 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 84 12 

clinical_engagement 
diagnosis 
demography 
67 new agents 
142 
disease_progression 
H-positive risk:  671 649 104 1117 434 85 1133 385 161 37 166 58 
H-negative risk:  649 671 1133 1117 385 434 85 104 166 161 58 37 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 84 12 

clinical_engagement 
diagnosis 
demography 
76 new agents 
143 
disease_progression 
H-positive risk:  667 646 104 1126 433 87 1134 380 164 35 163 61 
H-negative risk:  646 667 1134 1126 380 433 87 104 163 164 61 35 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 86 11 

clinical_engagement 
diagnosis 
demography 
81 new agents 
144 
disease_progression 
H-positive risk:  662 643 105 1137 432 89 1135 384 161 33 160 59 
H-negative risk:  643 662 1135 1137 384 432 89 105 160 161 59 33 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 87 12 

clinical_engagement 
diagnosis 
demography 
62 new agents 
145 
disease_progression 
H-positive risk:  672 644 105 1137 423 90 1134 382 163 34 159 57 
H-negative risk:  644 672 1134 1137 382 423 90 105 159 163 57 34 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 85 12 

clinical_engagement 
diagnosis 
demography 
92 new agents 
146 
disease_progression 
H-positive risk:  677 645 104 1140 422 90 1126 381 164 37 156 58 
H-negative risk:  645 677 1126 1140 381 422 90 104 156 164 58 37 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 86 11 

clinical_engagement 
diagnosis 
demography 
70 new agents 
147 
disease_progression 
H-positive risk:  677 648 105 1135 421 90 1127 383 164 38 155 57 
H-negative risk:  648 677 1127 1135 383 421 90 105 155 164 57 38 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 86 12 

clinical_engagement 
diagnosis 
demography 
76 new agents 
148 
disease_progression 
H-positive risk:  687 649 101 1136 420 90 1116 382 163 40 158 58 
H-negative risk:  649 687 1116 1136 382 420 90 101 158 163 58 40 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 84 12 

clinical_engagement 
diagnosis 
demography 
69 new agents 
149 
disease_progression 
H-positive risk:  686 644 98 1133 427 91 1120 382 163 42 159 55 
H-negative risk:  644 686 1120 1133 382 427 91 98 159 163 55 42 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 86 11 

clinical_engagement 
diagnosis 
demography 
87 new agents 
150 
disease_progression 
H-positive risk:  687 649 98 1125 421 94 1120 385 166 43 157 55 
H-negative risk:  649 687 1120 1125 385 421 94 98 157 166 55 43 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 84 12 

clinical_engagement 
diagnosis 
demography 
86 new agents 
151 
disease_progression 
H-positive risk:  686 651 92 1131 422 94 1113 386 164 44 162 55 
H-negative risk:  651 686 1113 1131 386 422 94 92 162 164 55 44 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 83 12 

clinical_engagement 
diagnosis 
demography 
76 new agents 
152 
disease_progression 
H-positive risk:  686 646 91 1134 420 97 1121 384 164 45 159 53 
H-negative risk:  646 686 1121 1134 384 420 97 91 159 164 53 45 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 85 13 

clinical_engagement 
diagnosis 
demography 
85 new agents 
153 
disease_progression 
H-positive risk:  681 642 94 1139 422 97 1119 389 161 45 159 52 
H-negative risk:  642 681 1119 1139 389 422 97 94 159 161 52 45 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 86 13 

clinical_engagement 
diagnosis 
demography 
82 new agents 
154 
disease_progression 
H-positive risk:  676 639 89 1147 422 96 1116 387 167 48 162 51 
H-negative risk:  639 676 1116 1147 387 422 96 89 162 167 51 48 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 84 13 

clinical_engagement 
diagnosis 
demography 
71 new agents 
155 
disease_progression 
H-positive risk:  676 652 85 1151 418 93 1100 391 171 47 164 52 
H-negative risk:  652 676 1100 1151 391 418 93 85 164 171 52 47 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 84 13 

clinical_engagement 
diagnosis 
demography 
85 new agents 
156 
disease_progression 
H-positive risk:  680 652 86 1148 411 93 1101 393 171 48 166 51 
H-negative risk:  652 680 1101 1148 393 411 93 86 166 171 51 48 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 87 13 

clinical_engagement 
diagnosis 
demography 
64 new agents 
157 
disease_progression 
H-positive risk:  681 658 84 1130 426 92 1093 400 171 48 168 49 
H-negative risk:  658 681 1093 1130 400 426 92 84 168 171 49 48 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 88 13 

clinical_engagement 
diagnosis 
demography 
102 new agents 
158 
disease_progression 
H-positive risk:  683 655 86 1133 434 92 1081 400 171 49 168 48 
H-negative risk:  655 683 1081 1133 400 434 92 86 168 171 48 49 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 86 12 

clinical_engagement 
diagnosis 
demography 
72 new agents 
159 
disease_progression 
H-positive risk:  672 662 85 1141 430 92 1084 401 168 51 167 47 
H-negative risk:  662 672 1084 1141 401 430 92 85 167 168 47 51 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 84 12 

clinical_engagement 
diagnosis 
demography 
74 new agents 
160 
disease_progression 
H-positive risk:  670 668 84 1133 434 93 1091 392 165 55 171 44 
H-negative risk:  668 670 1091 1133 392 434 93 84 171 165 44 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 85 12 

clinical_engagement 
diagnosis 
demography 
91 new agents 
161 
disease_progression 
H-positive risk:  673 675 80 1113 444 89 1098 387 168 52 178 43 
H-negative risk:  675 673 1098 1113 387 444 89 80 178 168 43 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 85 12 

clinical_engagement 
diagnosis 
demography 
71 new agents 
162 
disease_progression 
H-positive risk:  676 680 77 1105 448 89 1093 387 168 53 178 46 
H-negative risk:  680 676 1093 1105 387 448 89 77 178 168 46 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 85 12 

clinical_engagement 
diagnosis 
demography 
65 new agents 
163 
disease_progression 
H-positive risk:  674 681 78 1095 455 89 1098 393 166 53 173 45 
H-negative risk:  681 674 1098 1095 393 455 89 78 173 166 45 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 83 12 

clinical_engagement 
diagnosis 
demography 
79 new agents 
164 
disease_progression 
H-positive risk:  676 679 78 1086 462 90 1101 393 163 53 173 46 
H-negative risk:  679 676 1101 1086 393 462 90 78 173 163 46 53 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 84 12 

clinical_engagement 
diagnosis 
demography 
75 new agents 
165 
disease_progression 
H-positive risk:  677 673 78 1089 461 91 1107 388 164 54 170 48 
H-negative risk:  673 677 1107 1089 388 461 91 78 170 164 48 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 83 13 

clinical_engagement 
diagnosis 
demography 
89 new agents 
166 
disease_progression 
H-positive risk:  684 677 80 1082 459 92 1109 384 162 54 166 51 
H-negative risk:  677 684 1109 1082 384 459 92 80 166 162 51 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 82 15 

clinical_engagement 
diagnosis 
demography 
94 new agents 
167 
disease_progression 
H-positive risk:  696 679 76 1093 452 93 1107 371 162 54 169 48 
H-negative risk:  679 696 1107 1093 371 452 93 76 169 162 48 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 80 16 

clinical_engagement 
diagnosis 
demography 
57 new agents 
168 
disease_progression 
H-positive risk:  690 676 75 1095 452 92 1115 372 160 55 167 51 
H-negative risk:  676 690 1115 1095 372 452 92 75 167 160 51 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 81 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
169 
disease_progression 
H-positive risk:  682 670 76 1110 450 88 1115 374 162 57 163 53 
H-negative risk:  670 682 1115 1110 374 450 88 76 163 162 53 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 84 15 

clinical_engagement 
diagnosis 
demography 
97 new agents 
170 
disease_progression 
H-positive risk:  685 666 74 1116 453 89 1111 372 160 57 163 54 
H-negative risk:  666 685 1111 1116 372 453 89 74 163 160 54 57 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 83 14 

clinical_engagement 
diagnosis 
demography 
74 new agents 
171 
disease_progression 
H-positive risk:  686 669 73 1116 452 85 1115 370 159 59 161 55 
H-negative risk:  669 686 1115 1116 370 452 85 73 161 159 55 59 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 84 13 

clinical_engagement 
diagnosis 
demography 
76 new agents 
172 
disease_progression 
H-positive risk:  681 671 74 1116 457 88 1111 367 162 56 163 54 
H-negative risk:  671 681 1111 1116 367 457 88 74 163 162 54 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 86 13 

clinical_engagement 
diagnosis 
demography 
73 new agents 
173 
disease_progression 
H-positive risk:  686 662 74 1122 456 85 1116 365 168 54 163 49 
H-negative risk:  662 686 1116 1122 365 456 85 74 163 168 49 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 82 14 

clinical_engagement 
diagnosis 
demography 
55 new agents 
174 
disease_progression 
H-positive risk:  682 665 74 1122 461 86 1105 376 164 54 161 50 
H-negative risk:  665 682 1105 1122 376 461 86 74 161 164 50 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 84 14 

clinical_engagement 
diagnosis 
demography 
64 new agents 
175 
disease_progression 
H-positive risk:  681 665 75 1123 458 91 1102 376 164 55 158 52 
H-negative risk:  665 681 1102 1123 376 458 91 75 158 164 52 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 86 14 

clinical_engagement 
diagnosis 
demography 
81 new agents 
176 
disease_progression 
H-positive risk:  682 675 75 1120 457 92 1103 368 163 52 159 54 
H-negative risk:  675 682 1103 1120 368 457 92 75 159 163 54 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 86 15 

clinical_engagement 
diagnosis 
demography 
81 new agents 
177 
disease_progression 
H-positive risk:  684 674 75 1118 454 91 1109 363 164 52 159 57 
H-negative risk:  674 684 1109 1118 363 454 91 75 159 164 57 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
86 new agents 
178 
disease_progression 
H-positive risk:  680 677 77 1115 448 92 1114 362 163 50 164 58 
H-negative risk:  677 680 1114 1115 362 448 92 77 164 163 58 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
179 
disease_progression 
H-positive risk:  681 670 74 1116 449 94 1122 362 158 51 166 57 
H-negative risk:  670 681 1122 1116 362 449 94 74 166 158 57 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
72 new agents 
180 
disease_progression 
H-positive risk:  680 664 77 1114 456 91 1126 360 154 53 166 59 
H-negative risk:  664 680 1126 1114 360 456 91 77 166 154 59 53 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 80 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
181 
disease_progression 
H-positive risk:  687 672 77 1117 453 91 1120 351 150 55 167 60 
H-negative risk:  672 687 1120 1117 351 453 91 77 167 150 60 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 81 17 

clinical_engagement 
diagnosis 
demography 
85 new agents 
182 
disease_progression 
H-positive risk:  685 672 80 1107 458 92 1108 358 150 58 167 65 
H-negative risk:  672 685 1108 1107 358 458 92 80 167 150 65 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
183 
disease_progression 
H-positive risk:  688 675 81 1103 458 96 1101 361 152 56 165 64 
H-negative risk:  675 688 1101 1103 361 458 96 81 165 152 64 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
184 
disease_progression 
H-positive risk:  682 670 81 1104 460 97 1098 368 154 55 167 64 
H-negative risk:  670 682 1098 1104 368 460 97 81 167 154 64 55 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 80 16 

clinical_engagement 
diagnosis 
demography 
83 new agents 
185 
disease_progression 
H-positive risk:  687 669 83 1102 460 98 1087 373 150 59 165 67 
H-negative risk:  669 687 1087 1102 373 460 98 83 165 150 67 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 83 15 

clinical_engagement 
diagnosis 
demography 
79 new agents 
186 
disease_progression 
H-positive risk:  700 669 79 1108 448 99 1086 370 149 62 163 67 
H-negative risk:  669 700 1086 1108 370 448 99 79 163 149 67 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 84 16 

clinical_engagement 
diagnosis 
demography 
77 new agents 
187 
disease_progression 
H-positive risk:  702 667 77 1106 451 97 1090 365 151 62 167 65 
H-negative risk:  667 702 1090 1106 365 451 97 77 167 151 65 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 84 15 

clinical_engagement 
diagnosis 
demography 
49 new agents 
188 
disease_progression 
H-positive risk:  701 658 75 1112 451 100 1099 362 150 61 165 66 
H-negative risk:  658 701 1099 1112 362 451 100 75 165 150 66 61 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
85 new agents 
189 
disease_progression 
H-positive risk:  704 664 76 1104 449 101 1101 361 147 60 167 66 
H-negative risk:  664 704 1101 1104 361 449 101 76 167 147 66 60 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 83 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
190 
disease_progression 
H-positive risk:  702 665 78 1098 444 101 1110 363 144 62 169 64 
H-negative risk:  665 702 1110 1098 363 444 101 78 169 144 64 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 85 17 

clinical_engagement 
diagnosis 
demography 
75 new agents 
191 
disease_progression 
H-positive risk:  707 661 80 1112 439 101 1107 356 149 59 169 60 
H-negative risk:  661 707 1107 1112 356 439 101 80 169 149 60 59 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 83 17 

clinical_engagement 
diagnosis 
demography 
62 new agents 
192 
disease_progression 
H-positive risk:  713 659 77 1111 435 100 1104 360 148 62 168 63 
H-negative risk:  659 713 1104 1111 360 435 100 77 168 148 63 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
95 new agents 
193 
disease_progression 
H-positive risk:  720 655 79 1115 437 98 1102 356 149 60 164 65 
H-negative risk:  655 720 1102 1115 356 437 98 79 164 149 65 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
194 
disease_progression 
H-positive risk:  721 655 78 1097 453 96 1091 368 150 61 165 65 
H-negative risk:  655 721 1091 1097 368 453 96 78 165 150 65 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
86 new agents 
195 
disease_progression 
H-positive risk:  719 656 76 1108 451 96 1082 376 148 61 167 60 
H-negative risk:  656 719 1082 1108 376 451 96 76 167 148 60 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 88 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
196 
disease_progression 
H-positive risk:  724 651 75 1122 443 95 1079 376 148 62 165 60 
H-negative risk:  651 724 1079 1122 376 443 95 75 165 148 60 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
197 
disease_progression 
H-positive risk:  734 649 77 1118 436 97 1081 378 147 63 161 59 
H-negative risk:  649 734 1081 1118 378 436 97 77 161 147 59 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
91 new agents 
198 
disease_progression 
H-positive risk:  744 649 77 1119 432 97 1078 376 145 65 159 59 
H-negative risk:  649 744 1078 1119 376 432 97 77 159 145 59 65 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
199 
disease_progression 
H-positive risk:  743 648 77 1118 433 94 1087 373 146 64 162 55 
H-negative risk:  648 743 1087 1118 373 433 94 77 162 146 55 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
85 new agents 
200 
disease_progression 
H-positive risk:  741 643 77 1119 434 94 1083 382 149 64 163 51 
H-negative risk:  643 741 1083 1119 382 434 94 77 163 149 51 64 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
201 
disease_progression 
H-positive risk:  741 641 79 1117 435 94 1075 392 151 64 164 47 
H-negative risk:  641 741 1075 1117 392 435 94 79 164 151 47 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
89 new agents 
202 
disease_progression 
H-positive risk:  747 645 83 1108 435 100 1064 389 152 65 166 46 
H-negative risk:  645 747 1064 1108 389 435 100 83 166 152 46 65 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
203 
disease_progression 
H-positive risk:  739 641 83 1118 436 98 1073 383 152 66 166 45 
H-negative risk:  641 739 1073 1118 383 436 98 83 166 152 45 66 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
204 
disease_progression 
H-positive risk:  742 647 83 1120 433 98 1057 391 152 66 164 47 
H-negative risk:  647 742 1057 1120 391 433 98 83 164 152 47 66 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
90 new agents 
205 
disease_progression 
H-positive risk:  745 655 81 1123 433 99 1062 380 150 63 163 46 
H-negative risk:  655 745 1062 1123 380 433 99 81 163 150 46 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
206 
disease_progression 
H-positive risk:  740 657 81 1119 431 104 1052 390 148 66 166 46 
H-negative risk:  657 740 1052 1119 390 431 104 81 166 148 46 66 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
207 
disease_progression 
H-positive risk:  739 651 81 1116 445 103 1046 393 144 69 163 50 
H-negative risk:  651 739 1046 1116 393 445 103 81 163 144 50 69 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
208 
disease_progression 
H-positive risk:  734 648 81 1117 444 103 1050 397 146 69 162 49 
H-negative risk:  648 734 1050 1117 397 444 103 81 162 146 49 69 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
209 
disease_progression 
H-positive risk:  734 649 83 1113 449 104 1052 389 146 68 162 51 
H-negative risk:  649 734 1052 1113 389 449 104 83 162 146 51 68 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
210 
disease_progression 
H-positive risk:  731 653 81 1114 451 103 1054 386 147 67 161 52 
H-negative risk:  653 731 1054 1114 386 451 103 81 161 147 52 67 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
211 
disease_progression 
H-positive risk:  727 659 83 1118 451 104 1051 382 145 69 160 51 
H-negative risk:  659 727 1051 1118 382 451 104 83 160 145 51 69 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
212 
disease_progression 
H-positive risk:  727 660 85 1123 448 103 1053 379 148 69 157 48 
H-negative risk:  660 727 1053 1123 379 448 103 85 157 148 48 69 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
213 
disease_progression 
H-positive risk:  719 669 84 1118 445 105 1055 381 148 74 153 49 
H-negative risk:  669 719 1055 1118 381 445 105 84 153 148 49 74 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
214 
disease_progression 
H-positive risk:  719 672 84 1125 442 104 1061 369 148 74 154 48 
H-negative risk:  672 719 1061 1125 369 442 104 84 154 148 48 74 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
91 new agents 
215 
disease_progression 
H-positive risk:  711 673 87 1120 436 102 1066 379 149 75 156 46 
H-negative risk:  673 711 1066 1120 379 436 102 87 156 149 46 75 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
216 
disease_progression 
H-positive risk:  709 672 90 1126 430 103 1061 378 151 76 156 48 
H-negative risk:  672 709 1061 1126 378 430 103 90 156 151 48 76 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
217 
disease_progression 
H-positive risk:  702 675 86 1118 437 105 1067 386 147 72 157 48 
H-negative risk:  675 702 1067 1118 386 437 105 86 157 147 48 72 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
218 
disease_progression 
H-positive risk:  699 680 85 1108 441 106 1071 387 145 71 156 51 
H-negative risk:  680 699 1071 1108 387 441 106 85 156 145 51 71 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
219 
disease_progression 
H-positive risk:  694 678 84 1117 441 106 1067 385 148 70 156 54 
H-negative risk:  678 694 1067 1117 385 441 106 84 156 148 54 70 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
220 
disease_progression 
H-positive risk:  704 682 85 1108 439 104 1066 384 146 70 158 54 
H-negative risk:  682 704 1066 1108 384 439 104 85 158 146 54 70 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
221 
disease_progression 
H-positive risk:  707 676 88 1104 439 103 1061 397 147 68 158 52 
H-negative risk:  676 707 1061 1104 397 439 103 88 158 147 52 68 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
85 new agents 
222 
disease_progression 
H-positive risk:  708 667 90 1113 431 103 1069 392 148 67 160 52 
H-negative risk:  667 708 1069 1113 392 431 103 90 160 148 52 67 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
94 new agents 
223 
disease_progression 
H-positive risk:  711 676 91 1118 421 101 1067 392 151 65 155 52 
H-negative risk:  676 711 1067 1118 392 421 101 91 155 151 52 65 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
224 
disease_progression 
H-positive risk:  709 679 91 1113 422 101 1071 391 154 63 154 52 
H-negative risk:  679 709 1071 1113 391 422 101 91 154 154 52 63 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
225 
disease_progression 
H-positive risk:  709 675 90 1108 424 104 1077 388 157 61 155 52 
H-negative risk:  675 709 1077 1108 388 424 104 90 155 157 52 61 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
226 
disease_progression 
H-positive risk:  708 673 89 1101 422 106 1083 391 155 62 158 52 
H-negative risk:  673 708 1083 1101 391 422 106 89 158 155 52 62 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
227 
disease_progression 
H-positive risk:  705 676 91 1093 425 108 1081 399 153 61 156 52 
H-negative risk:  676 705 1081 1093 399 425 108 91 156 153 52 61 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 77 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
228 
disease_progression 
H-positive risk:  706 675 90 1086 427 110 1090 400 148 62 154 52 
H-negative risk:  675 706 1090 1086 400 427 110 90 154 148 52 62 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
229 
disease_progression 
H-positive risk:  702 673 86 1081 430 110 1093 407 147 63 155 53 
H-negative risk:  673 702 1093 1081 407 430 110 86 155 147 53 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 85 17 

clinical_engagement 
diagnosis 
demography 
75 new agents 
230 
disease_progression 
H-positive risk:  705 670 86 1084 428 111 1099 401 148 61 155 52 
H-negative risk:  670 705 1099 1084 401 428 111 86 155 148 52 61 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 83 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
231 
disease_progression 
H-positive risk:  705 678 85 1077 428 111 1100 402 149 58 154 53 
H-negative risk:  678 705 1100 1077 402 428 111 85 154 149 53 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 86 16 

clinical_engagement 
diagnosis 
demography 
79 new agents 
232 
disease_progression 
H-positive risk:  701 685 85 1087 424 110 1093 398 148 63 154 52 
H-negative risk:  685 701 1093 1087 398 424 110 85 154 148 52 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
61 new agents 
233 
disease_progression 
H-positive risk:  693 686 86 1081 432 111 1104 390 146 64 156 51 
H-negative risk:  686 693 1104 1081 390 432 111 86 156 146 51 64 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
95 new agents 
234 
disease_progression 
H-positive risk:  706 690 84 1083 438 108 1098 376 147 63 156 51 
H-negative risk:  690 706 1098 1083 376 438 108 84 156 147 51 63 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
235 
disease_progression 
H-positive risk:  704 694 83 1080 429 111 1110 374 146 62 155 52 
H-negative risk:  694 704 1110 1080 374 429 111 83 155 146 52 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
236 
disease_progression 
H-positive risk:  705 690 85 1080 433 111 1108 375 145 64 151 53 
H-negative risk:  690 705 1108 1080 375 433 111 85 151 145 53 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
237 
disease_progression 
H-positive risk:  696 691 83 1082 434 110 1119 369 143 65 155 53 
H-negative risk:  691 696 1119 1082 369 434 110 83 155 143 53 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
238 
disease_progression 
H-positive risk:  696 683 84 1073 435 108 1130 368 149 64 158 52 
H-negative risk:  683 696 1130 1073 368 435 108 84 158 149 52 64 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
239 
disease_progression 
H-positive risk:  697 692 84 1072 430 108 1130 365 152 62 156 52 
H-negative risk:  692 697 1130 1072 365 430 108 84 156 152 52 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
240 
disease_progression 
H-positive risk:  692 695 82 1071 431 107 1132 369 154 60 156 51 
H-negative risk:  695 692 1132 1071 369 431 107 82 156 154 51 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
241 
disease_progression 
H-positive risk:  692 692 82 1070 437 105 1127 379 150 61 150 55 
H-negative risk:  692 692 1127 1070 379 437 105 82 150 150 55 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
242 
disease_progression 
H-positive risk:  686 691 85 1078 425 102 1123 384 152 65 153 56 
H-negative risk:  691 686 1123 1078 384 425 102 85 153 152 56 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
243 
disease_progression 
H-positive risk:  683 692 85 1068 429 100 1137 382 152 63 153 56 
H-negative risk:  692 683 1137 1068 382 429 100 85 153 152 56 63 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
244 
disease_progression 
H-positive risk:  683 688 84 1066 432 99 1142 380 154 65 155 52 
H-negative risk:  688 683 1142 1066 380 432 99 84 155 154 52 65 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
245 
disease_progression 
H-positive risk:  675 690 83 1071 427 97 1154 377 157 63 154 52 
H-negative risk:  690 675 1154 1071 377 427 97 83 154 157 52 63 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
246 
disease_progression 
H-positive risk:  667 693 85 1076 417 98 1157 376 158 66 152 55 
H-negative risk:  693 667 1157 1076 376 417 98 85 152 158 55 66 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
247 
disease_progression 
H-positive risk:  663 696 84 1075 419 98 1161 377 157 65 151 54 
H-negative risk:  696 663 1161 1075 377 419 98 84 151 157 54 65 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
248 
disease_progression 
H-positive risk:  667 693 84 1078 418 97 1160 384 155 63 149 52 
H-negative risk:  693 667 1160 1078 384 418 97 84 149 155 52 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
249 
disease_progression 
H-positive risk:  668 695 83 1081 407 98 1155 392 155 63 151 52 
H-negative risk:  695 668 1155 1081 392 407 98 83 151 155 52 63 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
250 
disease_progression 
H-positive risk:  659 696 83 1076 412 98 1160 395 157 62 151 51 
H-negative risk:  696 659 1160 1076 395 412 98 83 151 157 51 62 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
251 
disease_progression 
H-positive risk:  653 699 85 1074 405 99 1164 398 154 65 153 51 
H-negative risk:  699 653 1164 1074 398 405 99 85 153 154 51 65 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
252 
disease_progression 
H-positive risk:  652 698 85 1071 406 99 1159 403 158 65 155 49 
H-negative risk:  698 652 1159 1071 403 406 99 85 155 158 49 65 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
88 new agents 
253 
disease_progression 
H-positive risk:  652 695 87 1075 405 99 1146 412 157 66 157 49 
H-negative risk:  695 652 1146 1075 412 405 99 87 157 157 49 66 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
98 new agents 
254 
disease_progression 
H-positive risk:  656 698 89 1069 394 95 1149 417 159 65 158 51 
H-negative risk:  698 656 1149 1069 417 394 95 89 158 159 51 65 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 69 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
255 
disease_progression 
H-positive risk:  661 699 90 1070 396 97 1143 414 158 65 158 49 
H-negative risk:  699 661 1143 1070 414 396 97 90 158 158 49 65 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 67 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
256 
disease_progression 
H-positive risk:  662 704 91 1063 394 98 1143 412 159 65 159 50 
H-negative risk:  704 662 1143 1063 412 394 98 91 159 159 50 65 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 64 21 

clinical_engagement 
diagnosis 
demography 
89 new agents 
257 
disease_progression 
H-positive risk:  665 700 93 1066 389 101 1141 414 158 65 160 48 
H-negative risk:  700 665 1141 1066 414 389 101 93 160 158 48 65 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 66 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
258 
disease_progression 
H-positive risk:  659 702 93 1059 393 101 1155 411 158 65 156 48 
H-negative risk:  702 659 1155 1059 411 393 101 93 156 158 48 65 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
259 
disease_progression 
H-positive risk:  653 698 93 1059 403 100 1156 414 157 65 155 47 
H-negative risk:  698 653 1156 1059 414 403 100 93 155 157 47 65 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 69 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
260 
disease_progression 
H-positive risk:  650 697 94 1061 406 100 1158 415 154 66 151 48 
H-negative risk:  697 650 1158 1061 415 406 100 94 151 154 48 66 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 69 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
261 
disease_progression 
H-positive risk:  648 697 94 1058 407 99 1156 426 153 67 146 49 
H-negative risk:  697 648 1156 1058 426 407 99 94 146 153 49 67 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
262 
disease_progression 
H-positive risk:  645 694 96 1065 407 99 1154 428 152 68 143 49 
H-negative risk:  694 645 1154 1065 428 407 99 96 143 152 49 68 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
59 new agents 
263 
disease_progression 
H-positive risk:  643 689 100 1065 410 99 1156 429 151 68 142 48 
H-negative risk:  689 643 1156 1065 429 410 99 100 142 151 48 68 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
93 new agents 
264 
disease_progression 
H-positive risk:  644 687 102 1068 410 100 1163 428 148 64 137 49 
H-negative risk:  687 644 1163 1068 428 410 100 102 137 148 49 64 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
265 
disease_progression 
H-positive risk:  646 691 103 1058 416 101 1159 431 144 65 137 49 
H-negative risk:  691 646 1159 1058 431 416 101 103 137 144 49 65 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
98 new agents 
266 
disease_progression 
H-positive risk:  653 692 106 1057 416 104 1146 429 143 66 137 51 
H-negative risk:  692 653 1146 1057 429 416 104 106 137 143 51 66 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 76 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
267 
disease_progression 
H-positive risk:  647 695 103 1064 414 103 1154 425 144 64 135 52 
H-negative risk:  695 647 1154 1064 425 414 103 103 135 144 52 64 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
268 
disease_progression 
H-positive risk:  650 692 102 1067 411 101 1149 434 144 63 133 54 
H-negative risk:  692 650 1149 1067 434 411 101 102 133 144 54 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
269 
disease_progression 
H-positive risk:  646 697 100 1066 412 99 1147 434 148 61 138 52 
H-negative risk:  697 646 1147 1066 434 412 99 100 138 148 52 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
270 
disease_progression 
H-positive risk:  646 693 100 1065 410 97 1150 442 149 60 136 52 
H-negative risk:  693 646 1150 1065 442 410 97 100 136 149 52 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
271 
disease_progression 
H-positive risk:  646 687 101 1067 414 100 1156 438 144 62 133 52 
H-negative risk:  687 646 1156 1067 438 414 100 101 133 144 52 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
272 
disease_progression 
H-positive risk:  646 689 100 1064 417 99 1154 435 148 61 132 55 
H-negative risk:  689 646 1154 1064 435 417 99 100 132 148 55 61 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
273 
disease_progression 
H-positive risk:  650 679 101 1071 421 98 1152 426 151 59 134 58 
H-negative risk:  679 650 1152 1071 426 421 98 101 134 151 58 59 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
274 
disease_progression 
H-positive risk:  641 678 98 1073 426 99 1162 429 148 59 134 53 
H-negative risk:  678 641 1162 1073 429 426 99 98 134 148 53 59 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
88 new agents 
275 
disease_progression 
H-positive risk:  647 685 97 1064 426 101 1158 427 148 57 133 57 
H-negative risk:  685 647 1158 1064 427 426 101 97 133 148 57 57 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
276 
disease_progression 
H-positive risk:  646 694 100 1063 423 99 1161 423 149 58 128 56 
H-negative risk:  694 646 1161 1063 423 423 99 100 128 149 56 58 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
277 
disease_progression 
H-positive risk:  649 685 101 1070 431 99 1155 416 151 58 128 57 
H-negative risk:  685 649 1155 1070 416 431 99 101 128 151 57 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
278 
disease_progression 
H-positive risk:  642 690 100 1072 423 98 1156 421 153 57 125 63 
H-negative risk:  690 642 1156 1072 421 423 98 100 125 153 63 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
279 
disease_progression 
H-positive risk:  644 692 99 1069 430 94 1152 419 155 60 123 63 
H-negative risk:  692 644 1152 1069 419 430 94 99 123 155 63 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
280 
disease_progression 
H-positive risk:  649 691 101 1065 429 96 1151 413 159 60 123 63 
H-negative risk:  691 649 1151 1065 413 429 96 101 123 159 63 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
63 new agents 
281 
disease_progression 
H-positive risk:  648 699 99 1061 429 96 1151 417 157 56 125 62 
H-negative risk:  699 648 1151 1061 417 429 96 99 125 157 62 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
282 
disease_progression 
H-positive risk:  646 699 98 1069 422 96 1151 425 151 58 122 63 
H-negative risk:  699 646 1151 1069 425 422 96 98 122 151 63 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
283 
disease_progression 
H-positive risk:  651 699 102 1071 423 96 1144 415 154 60 122 63 
H-negative risk:  699 651 1144 1071 415 423 96 102 122 154 63 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
284 
disease_progression 
H-positive risk:  654 690 102 1076 425 97 1140 420 151 61 121 63 
H-negative risk:  690 654 1140 1076 420 425 97 102 121 151 63 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
285 
disease_progression 
H-positive risk:  650 694 103 1077 425 97 1144 415 151 61 121 62 
H-negative risk:  694 650 1144 1077 415 425 97 103 121 151 62 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
286 
disease_progression 
H-positive risk:  642 692 103 1078 426 97 1142 422 151 59 125 63 
H-negative risk:  692 642 1142 1078 422 426 97 103 125 151 63 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
287 
disease_progression 
H-positive risk:  640 688 102 1083 430 98 1145 416 150 58 127 63 
H-negative risk:  688 640 1145 1083 416 430 98 102 127 150 63 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
288 
disease_progression 
H-positive risk:  642 685 106 1088 423 99 1138 420 150 59 125 65 
H-negative risk:  685 642 1138 1088 420 423 99 106 125 150 65 59 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
289 
disease_progression 
H-positive risk:  643 689 106 1086 425 99 1136 428 146 56 123 63 
H-negative risk:  689 643 1136 1086 428 425 99 106 123 146 63 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
290 
disease_progression 
H-positive risk:  642 688 103 1092 420 97 1133 433 144 61 125 62 
H-negative risk:  688 642 1133 1092 433 420 97 103 125 144 62 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
291 
disease_progression 
H-positive risk:  635 681 105 1093 423 96 1134 443 144 59 126 61 
H-negative risk:  681 635 1134 1093 443 423 96 105 126 144 61 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
62 new agents 
292 
disease_progression 
H-positive risk:  642 675 103 1097 416 95 1144 438 144 57 128 61 
H-negative risk:  675 642 1144 1097 438 416 95 103 128 144 61 57 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
293 
disease_progression 
H-positive risk:  643 681 103 1092 408 95 1148 436 150 55 128 61 
H-negative risk:  681 643 1148 1092 436 408 95 103 128 150 61 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
294 
disease_progression 
H-positive risk:  642 681 104 1094 410 97 1148 427 146 58 129 64 
H-negative risk:  681 642 1148 1094 427 410 97 104 129 146 64 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
295 
disease_progression 
H-positive risk:  646 683 105 1091 407 97 1150 430 147 53 128 63 
H-negative risk:  683 646 1150 1091 430 407 97 105 128 147 63 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
296 
disease_progression 
H-positive risk:  648 683 105 1083 415 96 1146 431 149 54 127 63 
H-negative risk:  683 648 1146 1083 431 415 96 105 127 149 63 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
297 
disease_progression 
H-positive risk:  651 685 106 1082 414 94 1136 437 154 53 125 63 
H-negative risk:  685 651 1136 1082 437 414 94 106 125 154 63 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
298 
disease_progression 
H-positive risk:  654 687 107 1070 416 91 1133 442 158 53 124 65 
H-negative risk:  687 654 1133 1070 442 416 91 107 124 158 65 53 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
299 
disease_progression 
H-positive risk:  657 684 107 1074 422 90 1120 444 159 54 123 66 
H-negative risk:  684 657 1120 1074 444 422 90 107 123 159 66 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
300 
disease_progression 
H-positive risk:  659 680 106 1075 422 88 1120 451 159 53 123 64 
H-negative risk:  680 659 1120 1075 451 422 88 106 123 159 64 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
301 
disease_progression 
H-positive risk:  656 681 108 1074 421 92 1120 448 159 52 122 67 
H-negative risk:  681 656 1120 1074 448 421 92 108 122 159 67 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
87 new agents 
302 
disease_progression 
H-positive risk:  652 677 108 1072 422 92 1135 443 162 47 122 68 
H-negative risk:  677 652 1135 1072 443 422 92 108 122 162 68 47 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
303 
disease_progression 
H-positive risk:  655 680 109 1061 425 92 1138 442 162 45 125 66 
H-negative risk:  680 655 1138 1061 442 425 92 109 125 162 66 45 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
86 new agents 
304 
disease_progression 
H-positive risk:  656 679 108 1068 420 92 1131 442 167 46 126 65 
H-negative risk:  679 656 1131 1068 442 420 92 108 126 167 65 46 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
305 
disease_progression 
H-positive risk:  660 682 107 1066 417 92 1119 443 166 49 130 69 
H-negative risk:  682 660 1119 1066 443 417 92 107 130 166 69 49 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 76 29 

clinical_engagement 
diagnosis 
demography 
73 new agents 
306 
disease_progression 
H-positive risk:  663 679 107 1074 413 93 1117 444 164 47 133 66 
H-negative risk:  679 663 1117 1074 444 413 93 107 133 164 66 47 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
307 
disease_progression 
H-positive risk:  668 678 106 1077 416 95 1121 432 163 48 129 67 
H-negative risk:  678 668 1121 1077 432 416 95 106 129 163 67 48 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
64 new agents 
308 
disease_progression 
H-positive risk:  666 681 106 1071 424 97 1115 431 168 48 128 65 
H-negative risk:  681 666 1115 1071 431 424 97 106 128 168 65 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
309 
disease_progression 
H-positive risk:  678 684 106 1067 430 95 1107 425 168 46 129 65 
H-negative risk:  684 678 1107 1067 425 430 95 106 129 168 65 46 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
310 
disease_progression 
H-positive risk:  682 682 104 1052 441 94 1106 428 169 45 130 67 
H-negative risk:  682 682 1106 1052 428 441 94 104 130 169 67 45 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
68 new agents 
311 
disease_progression 
H-positive risk:  695 680 105 1049 439 95 1095 427 169 45 134 67 
H-negative risk:  680 695 1095 1049 427 439 95 105 134 169 67 45 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
83 new agents 
312 
disease_progression 
H-positive risk:  698 683 100 1045 445 97 1100 419 163 46 133 71 
H-negative risk:  683 698 1100 1045 419 445 97 100 133 163 71 46 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
313 
disease_progression 
H-positive risk:  697 678 98 1060 444 95 1095 417 164 47 132 73 
H-negative risk:  678 697 1095 1060 417 444 95 98 132 164 73 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
314 
disease_progression 
H-positive risk:  697 672 99 1062 450 96 1093 416 166 45 133 71 
H-negative risk:  672 697 1093 1062 416 450 96 99 133 166 71 45 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
315 
disease_progression 
H-positive risk:  695 667 103 1061 450 94 1099 414 166 46 135 70 
H-negative risk:  667 695 1099 1061 414 450 94 103 135 166 70 46 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
316 
disease_progression 
H-positive risk:  687 664 101 1062 453 96 1108 415 164 46 135 69 
H-negative risk:  664 687 1108 1062 415 453 96 101 135 164 69 46 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
317 
disease_progression 
H-positive risk:  684 661 100 1062 456 92 1115 414 164 51 134 67 
H-negative risk:  661 684 1115 1062 414 456 92 100 134 164 67 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
318 
disease_progression 
H-positive risk:  688 657 101 1061 457 91 1118 414 166 52 131 64 
H-negative risk:  657 688 1118 1061 414 457 91 101 131 166 64 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
319 
disease_progression 
H-positive risk:  690 652 100 1063 456 95 1108 421 162 56 135 62 
H-negative risk:  652 690 1108 1063 421 456 95 100 135 162 62 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
320 
disease_progression 
H-positive risk:  687 648 102 1068 458 95 1108 422 163 57 135 57 
H-negative risk:  648 687 1108 1068 422 458 95 102 135 163 57 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
321 
disease_progression 
H-positive risk:  694 657 98 1069 450 93 1108 417 166 57 137 54 
H-negative risk:  657 694 1108 1069 417 450 93 98 137 166 54 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
322 
disease_progression 
H-positive risk:  688 653 94 1071 453 92 1116 416 166 61 137 53 
H-negative risk:  653 688 1116 1071 416 453 92 94 137 166 53 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
90 new agents 
323 
disease_progression 
H-positive risk:  691 654 91 1070 448 97 1112 415 166 63 140 53 
H-negative risk:  654 691 1112 1070 415 448 97 91 140 166 53 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
324 
disease_progression 
H-positive risk:  680 651 95 1074 444 96 1124 411 166 66 139 54 
H-negative risk:  651 680 1124 1074 411 444 96 95 139 166 54 66 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
325 
disease_progression 
H-positive risk:  687 646 96 1069 447 95 1123 412 165 69 137 54 
H-negative risk:  646 687 1123 1069 412 447 95 96 137 165 54 69 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
326 
disease_progression 
H-positive risk:  681 646 96 1088 438 96 1121 408 164 68 140 54 
H-negative risk:  646 681 1121 1088 408 438 96 96 140 164 54 68 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
327 
disease_progression 
H-positive risk:  685 645 99 1083 441 95 1117 409 162 69 141 54 
H-negative risk:  645 685 1117 1083 409 441 95 99 141 162 54 69 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
328 
disease_progression 
H-positive risk:  688 642 100 1084 440 92 1121 402 167 65 143 56 
H-negative risk:  642 688 1121 1084 402 440 92 100 143 167 56 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
329 
disease_progression 
H-positive risk:  690 648 98 1083 433 92 1129 398 166 62 146 55 
H-negative risk:  648 690 1129 1083 398 433 92 98 146 166 55 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
330 
disease_progression 
H-positive risk:  685 645 97 1081 440 89 1129 403 165 61 148 57 
H-negative risk:  645 685 1129 1081 403 440 89 97 148 165 57 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
331 
disease_progression 
H-positive risk:  683 644 97 1078 439 89 1129 409 163 64 147 58 
H-negative risk:  644 683 1129 1078 409 439 89 97 147 163 58 64 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
58 new agents 
332 
disease_progression 
H-positive risk:  684 650 95 1067 438 85 1130 414 170 63 147 57 
H-negative risk:  650 684 1130 1067 414 438 85 95 147 170 57 63 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
333 
disease_progression 
H-positive risk:  683 651 94 1067 424 85 1142 416 168 63 150 57 
H-negative risk:  651 683 1142 1067 416 424 85 94 150 168 57 63 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
334 
disease_progression 
H-positive risk:  683 659 96 1069 417 84 1139 413 165 66 154 55 
H-negative risk:  659 683 1139 1069 413 417 84 96 154 165 55 66 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
335 
disease_progression 
H-positive risk:  682 653 94 1073 416 83 1146 415 165 68 153 52 
H-negative risk:  653 682 1146 1073 415 416 83 94 153 165 52 68 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
336 
disease_progression 
H-positive risk:  689 651 92 1071 414 85 1134 428 162 69 154 51 
H-negative risk:  651 689 1134 1071 428 414 85 92 154 162 51 69 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
337 
disease_progression 
H-positive risk:  691 655 95 1066 413 84 1133 424 166 68 154 51 
H-negative risk:  655 691 1133 1066 424 413 84 95 154 166 51 68 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
92 new agents 
338 
disease_progression 
H-positive risk:  683 649 93 1088 411 87 1126 419 167 70 157 50 
H-negative risk:  649 683 1126 1088 419 411 87 93 157 167 50 70 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
339 
disease_progression 
H-positive risk:  686 652 92 1089 415 88 1119 415 169 67 158 50 
H-negative risk:  652 686 1119 1089 415 415 88 92 158 169 50 67 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
340 
disease_progression 
H-positive risk:  687 648 90 1086 426 85 1123 409 168 68 161 49 
H-negative risk:  648 687 1123 1086 409 426 85 90 161 168 49 68 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
61 new agents 
341 
disease_progression 
H-positive risk:  685 643 92 1080 428 83 1122 422 168 68 162 47 
H-negative risk:  643 685 1122 1080 422 428 83 92 162 168 47 68 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
342 
disease_progression 
H-positive risk:  676 645 93 1082 429 86 1131 420 166 67 157 48 
H-negative risk:  645 676 1131 1082 420 429 86 93 157 166 48 67 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
90 new agents 
343 
disease_progression 
H-positive risk:  672 643 91 1080 433 84 1130 423 169 69 157 49 
H-negative risk:  643 672 1130 1080 423 433 84 91 157 169 49 69 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
344 
disease_progression 
H-positive risk:  676 646 93 1080 425 86 1126 427 164 70 159 48 
H-negative risk:  646 676 1126 1080 427 425 86 93 159 164 48 70 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
345 
disease_progression 
H-positive risk:  677 642 93 1085 417 84 1133 431 160 72 156 50 
H-negative risk:  642 677 1133 1085 431 417 84 93 156 160 50 72 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
346 
disease_progression 
H-positive risk:  669 636 94 1082 421 83 1123 442 165 74 157 54 
H-negative risk:  636 669 1123 1082 442 421 83 94 157 165 54 74 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
347 
disease_progression 
H-positive risk:  675 631 95 1085 415 82 1122 442 167 73 158 55 
H-negative risk:  631 675 1122 1085 442 415 82 95 158 167 55 73 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
348 
disease_progression 
H-positive risk:  675 631 95 1084 412 86 1125 439 168 72 157 56 
H-negative risk:  631 675 1125 1084 439 412 86 95 157 168 56 72 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
349 
disease_progression 
H-positive risk:  673 636 94 1085 409 83 1127 439 171 71 155 57 
H-negative risk:  636 673 1127 1085 439 409 83 94 155 171 57 71 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 68 26 

clinical_engagement 
diagnosis 
demography 
88 new agents 
350 
disease_progression 
H-positive risk:  683 634 96 1080 413 84 1132 431 168 70 152 57 
H-negative risk:  634 683 1132 1080 431 413 84 96 152 168 57 70 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
351 
disease_progression 
H-positive risk:  681 636 95 1071 425 87 1125 434 167 68 152 59 
H-negative risk:  636 681 1125 1071 434 425 87 95 152 167 59 68 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 68 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
352 
disease_progression 
H-positive risk:  675 636 93 1076 433 88 1125 430 164 69 153 58 
H-negative risk:  636 675 1125 1076 430 433 88 93 153 164 58 69 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 69 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
353 
disease_progression 
H-positive risk:  676 632 93 1077 433 83 1124 439 165 67 155 56 
H-negative risk:  632 676 1124 1077 439 433 83 93 155 165 56 67 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 70 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
354 
disease_progression 
H-positive risk:  680 641 94 1073 441 84 1110 445 159 68 150 55 
H-negative risk:  641 680 1110 1073 445 441 84 94 150 159 55 68 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 69 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
355 
disease_progression 
H-positive risk:  685 648 93 1070 435 85 1105 452 159 63 151 54 
H-negative risk:  648 685 1105 1070 452 435 85 93 151 159 54 63 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 67 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
356 
disease_progression 
H-positive risk:  682 649 94 1077 434 86 1104 450 159 60 150 55 
H-negative risk:  649 682 1104 1077 450 434 86 94 150 159 55 60 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 70 27 

clinical_engagement 
diagnosis 
demography 
91 new agents 
357 
disease_progression 
H-positive risk:  686 647 94 1081 425 89 1106 452 161 58 147 54 
H-negative risk:  647 686 1106 1081 452 425 89 94 147 161 54 58 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 69 27 

clinical_engagement 
diagnosis 
demography 
98 new agents 
358 
disease_progression 
H-positive risk:  699 654 96 1082 416 91 1102 443 156 60 146 55 
H-negative risk:  654 699 1102 1082 443 416 91 96 146 156 55 60 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 70 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
359 
disease_progression 
H-positive risk:  699 659 93 1083 409 91 1099 448 156 59 150 54 
H-negative risk:  659 699 1099 1083 448 409 91 93 150 156 54 59 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 71 26 

clinical_engagement 
diagnosis 
demography 
92 new agents 
360 
disease_progression 
H-positive risk:  696 661 93 1085 411 91 1092 450 152 62 153 54 
H-negative risk:  661 696 1092 1085 450 411 91 93 153 152 54 62 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
70 new agents 
Time difference of 15.6647 mins
This is task 26
